Key result
Percutaneous VT ablation remains challenging with moderate success and significant complications despite 3D mapping improvements.
Why the study?
Despite advances in catheter ablation for ventricular tachycardia in structural heart disease, procedure times remain comparatively long, complication rates significant, and success rates for certain subtypes moderate.
Persistent challenges in percutaneous VT ablation warrant caution in patient selection; leaves open whether novel technologies will improve outcomes.
Percutaneous catheter ablation for ventricular tachycardia (VT) in structural heart disease is an important adjunctive treatment option to reduce overall VT burden and recurrence, ICD shocks and hospitalization by eliminating or excluding the arrhythmogenic substrate.1 Yet, despite encouraging results with a trend towards improved survival in registry data following VT ablation2 as well as improvements in preprocedural substrate characterization and high density electro-anatomical 3D mapping, procedure times remain comparatively long, complication rates significant and success rates for certain VT subtypes are, at best, moderate.
No takes yet. Share an insight, caveat, or question.
Tonko et al. (2023) conducted an editorial in Ventricular tachycardia in structural heart disease. Rapid high-density contact mapping using a novel star-shaped multipolar catheter was evaluated. Despite improvements in 3D mapping, percutaneous catheter ablation for ventricular tachycardia remains challenging with long procedure times, significant complication rates, and moderate success rates.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: